COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1680: Articles 16791-16800  | Next

Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants
Ferrari, M., Mekkaoui, L., Ilca, F. T., Akbar, Z., Bughda, R., Lamb, K., Ward, K., Parekh, F., Karattil, R., Allen, C., Wu, P., Baldan, V., Mattiuzzo, G., Bentley, E. M., Takeuchi, Y., Sillibourne, J., Datta, P., Kinna, A., Pule, M., Onuoha, S.
10.1101/2021.03.17.435802 — Posted: 2021-03-17
Show us the Data: Global COVID-19 Wastewater Monitoring Efforts, Equity, and Gaps
Naughton, C. C., Roman, F. A., Alvarado, A. G. F., Tariqi, A. Q., Deeming, M. A., Bibby, K., Bivins, A., Rose, J. B., Medema, G., Ahmed, W., Katsivelis, P., Allan, V., Sinclair, R., Zhang, Y., Kinyua, M. N.
10.1101/2021.03.14.21253564 — Posted: 2021-03-17
In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2.
ElZein, R., Abdel Sater, f., Fakhreddine, S., Abi Hanna, P., Feghali, R., Hamad, H., Ayoub, F.
10.1101/2021.03.07.21252302 — Posted: 2021-03-17
Knowledge barriers in the symptomatic-COVID-19 testing programme in the UK: an observational study
Graham, M. S., May, A., Varsavsky, T., Sudre, C., Murray, B., Klaser, K., Antonelli, M., Canas, L., Molteni, E., Modat, M., Drew, D. A., Nguyen, L., Rader, B., Hu, C., Capdevila, J., Hammers, A., Chan, A., Wolf, J., Brownstein, J., Spector, T., Ourselin, S., Steves, C., Astley, C.
10.1101/2021.03.16.21253719 — Posted: 2021-03-17
High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study
Das, A., Weaver, L., Saffaran, S., Yehya, N., Scott, T. E., Chikhani, M., Laffey, J. G., Hardman, J. G., Camporota, L., Bates, D.
10.1101/2021.03.17.21253788 — Posted: 2021-03-17
THE EFFECTIVENESS OF ACB-IP 1.0 UNIVERSAL PATHOGEN FREE CONCENTRATED COCKTAIL CONVALESCENT PLASMA IN COVID-19 INFECTION
Hemsinlioglu, C., Pelit, N. B., Yalcin, K., Gunaydin, O. S., Ozturk Sahin, N., Savas Karagacli, E., Elibol, O., Demir, S. O., Safak, E., Turan, R. D., Celebi, G., Kocaoglu, M. E., Sir Karakus, G., Yurtsever, B., Tastan, C., Abanuz, S., Cakirsoy, D., Dilek Kancagi, D., Torun, Z., Seyis, U., Elek, M., Zengin, R., Kocagoz, A. S., Cuhadaroglu, C., Birgen, N., Ratip, S., Ovali, E.
10.1101/2021.03.05.21251413 — Posted: 2021-03-17
Metagenomic sequencing of municipal wastewater provides a near-complete SARS-CoV-2 genome sequence identified as the B.1.1.7 variant of concern from a Canadian municipality concurrent with an outbreak
Landgraff, C., Wang, L. Y. R., Buchanan, C., Wells, M., Schonfeld, J., Bessonov, K., Ali, J., Robert, E., Nadon, C.
10.1101/2021.03.11.21253409 — Posted: 2021-03-17
Estimating the increased transmissibility of the B.1.1.7 strain over previously circulating strains in England using fractions of GISAID sequences and the distribution of serial intervals
Piantham, C., Ito, K.
10.1101/2021.03.17.21253775 — Posted: 2021-03-17
A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
Ives, A. R., Bozzuto, C.
10.1101/2021.03.17.21253793 — Posted: 2021-03-17
B.1.1.7 became the dominant variant in Lebanon.
younes, M., Hamze, K., Osman, K. L., Carter, D. P., Pullan, S. T., Caroll, M., Vipond, R. T., Mohamad, N., nassar, h., Ghaddar, M., Makki, M., Nguewa, P., Abdel Sater, f.
10.1101/2021.03.17.21253782 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).